Becton Dickinsonvs.GE HealthCare
BDX vs GEHC · both in Medtech & devices, part of the Medicine, pharma & life science value chain: Medical equipment and devices, from surgery and cardiology to robotics.
Becton Dickinson is about 1.7× larger than GE HealthCare by market cap; GE HealthCare trades at the lower P/E (14.6 vs 51.8); year to date, Becton Dickinson leads (+18.1% vs −21.2%).
Side by side
| BDX | GEHC | |
|---|---|---|
| Market cap | $48.8B | $29B |
| Price | $182.75 | $64.22 |
| Today | +1.4% | −0.7% |
| Return YTD | +18.1% | −21.2% |
| Return 1Y | +19.0% | −13.2% |
| Since June 26, 2026 | +17.2% | −2.3% |
| P/E | 51.8 | 14.6 |
| P/S | 2.3 | 1.4 |
| P/B | 2.0 | 2.6 |
Data as of 2026-10-08 · updates daily after U.S. close
Since June 26, 2026: the change in the closing price, from the daily closes Sectivia records itself since that date.
The two companies
Becton DickinsonBDX
Syringes and needles sit at the recognisable end of the range. Becton Dickinson's portfolio is broad, spanning medical consumables alongside diagnostic systems and drug delivery equipment.
Full BDX profile →GE HealthCareGEHC
Imaging is the core: CT and MRI systems, plus ultrasound. Patient monitoring equipment and contrast agents round out a range sold worldwide.
Full GEHC profile →More BDX & GEHC comparisons
Other head-to-heads in the Medtech & devices segment.